Solenic Medical Inc.

Solenic Medical, Inc. is a clinical-stage medical device company based in College Station, Texas. Founded in February 2019, it focuses on non-invasive treatments for infected metallic implants, particularly prosthetic joint infections (PJIs). The company utilizes patented Alternating Magnetic Field (AMF) technology, which has received designation as a U.S. FDA Breakthrough Device. This innovative approach generates targeted heat on metallic implants to disrupt bacterial biofilms, enhancing the effectiveness of antibiotics and surgical interventions.

Solenic's primary target is the orthopedic market, specifically addressing PJIs in knee and hip implants, as well as infections in trauma-related implants. The company aims to serve fellowship-trained revision specialists, a select group of surgeons who manage complex joint infections. With a significant market opportunity projected to reach $2.5 billion by 2025, Solenic is well-positioned to make a meaningful impact in the healthcare sector. The leadership team includes experienced professionals from various fields, ensuring a strong foundation for the company's growth and innovation.